National Organization of African-Americans in Housing

The National Organization of African-Americans in Housing (NOAAH) is U.S. non-profit group that provides support services to member advocates for better housing.

On its website NOAAH states that its "national network of proactive housing advocates partner with industry and government to design and implement fair housing policies and programs as well as innovative strategies that improve the quality of housing services delivery and promote healthy, vibrant communities." [1]

NOAAH Opposes rBGH-Free Milk Marketing

While NOAAH's primary focus in on the quality of housing, in December 2006 it curiously issued a public statement calling on the U.S. Food and Drug Administration to ban dairy companies from marketing milk as free of from Monsanto's recombinant bovine growth hormone. NOAAH claims that the milk produced without using rGBH is "identical" to that using the drug and that marketing milk as free of the hormone was a "deceptive practice" that "is generating unnecessary confusion and anxiety" among low-income consumers. [2] In a letter to the FDA reproduced with the media release on the website of Truth About Trade and Technology - a pro-biotech group, NOAAH Board Secretary Kevin Marchman, urged the FDA "to stop this type of deceptive milk-labeling practice that cheats consumers and raises unwarranted fears." [3]

NOAAH's Corporate Partners

• Mortgage Guaranty Insurance Corporation
• The Sherwin-Williams Company
• Siemens
• UBS

Financial Details

NOAAH is designated as a 501(c)(6) organization under the US tax code.

Personnel

• Kevin Marchman, Board Secretary

Contact Details

National Organization of African Americans in Housing
507 Capitol Court, NE
Suite 300
Washington, DC 20002
Phone: (202) 544-1058
Fax: (202) 544 1059
Web: http://www.noaah.org

External links

• National Organization of African-Americans in Housing, "African-American Organization Urges FDA to Stop Deceptive Marketing of ‘No rBST Milk’", Media Release,
• Kevin Marchman, Board Secretary NOAAH, "Letter to Dr. Andrew von Eschenbach, Commissioner U.S. Food & Drug Administration", undated, December 2006.

This article is a stub. You can help by expanding it.